Literature DB >> 11223203

Initiation of a Sarcocystis neurona expressed sequence tag (EST) sequencing project: a preliminary report.

D K Howe1.   

Abstract

To accelerate genetic and molecular characterization of Sarcocystis neurona, the primary causative agent of equine protozoal myeloencephalitis (EPM), a sequencing project has been initiated that will generate approximately 7000-8000 expressed sequence tags (ESTs) from this apicomplexan parasite. Poly(A)(+) RNA was isolated from culture-derived S. neurona merozoites, and a cDNA library was constructed in a unidirectional lambda phage cloning vector. Sixty phage clones were randomly picked from the library, and the cDNA inserts were amplified from these clones using the T3 and T7 primers that flank the multi-cloning site of the lambda vector. This analysis demonstrated that 100% (60/60) of the clones selected from this library contained recombinant cDNA inserts ranging in size from 0.4 to 4.0 kilobases (kb) with an average size of 1.23kb. Single-pass sequencing from the 5' end of the 60 amplified cDNAs produced high-quality nucleotide sequence from 53 of the clones. Comparison of these ESTs to the current gene databases revealed significant matches for 10 of the ESTs, six of which are similar to sequences from other Apicomplexa (i.e., Toxoplasma gondii). Importantly, none of the ESTs were of obvious mammalian origin, thus indicating that the cDNAs in this library were derived primarily from parasite mRNA and not from mRNA of the bovine turbinate host cells. Collectively, these data indicate that the described cDNA library will provide an excellent substrate for generating a portion of the ESTs that are planned from S. neurona. This sequencing project will greatly hasten gene discovery for this protozoan pathogen thereby enhancing efforts towards the development of improved diagnostics, treatments, and preventatives for EPM. In addition, the S. neurona ESTs will represent a significant contribution to the extensive database of sequences from the Apicomplexa. Comparative analyses of these apicomplexan sequences will likely offer a multitude of important information about the biology and evolutionary history of this phylogenetic grouping of parasites.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223203     DOI: 10.1016/s0304-4017(00)00418-0

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database.

Authors:  Li Li; Brian P Brunk; Jessica C Kissinger; Deana Pape; Keliang Tang; Robert H Cole; John Martin; Todd Wylie; Mike Dante; Steven J Fogarty; Daniel K Howe; Paul Liberator; Carmen Diaz; Jennifer Anderson; Michael White; Maria E Jerome; Emily A Johnson; Jay A Radke; Christian J Stoeckert; Robert H Waterston; Sandra W Clifton; David S Roos; L David Sibley
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

2.  The origins of apicomplexan sequence innovation.

Authors:  James Wasmuth; Jennifer Daub; José Manuel Peregrín-Alvarez; Constance A M Finney; John Parkinson
Journal:  Genome Res       Date:  2009-04-10       Impact factor: 9.043

3.  Sarcocystis neurona merozoites express a family of immunogenic surface antigens that are orthologues of the Toxoplasma gondii surface antigens (SAGs) and SAG-related sequences.

Authors:  Daniel K Howe; Rajshekhar Y Gaji; Meaghan Mroz-Barrett; Marc-Jan Gubbels; Boris Striepen; Shelby Stamper
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 4.  An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).

Authors:  J P Dubey; D K Howe; M Furr; W J Saville; A E Marsh; S M Reed; M E Grigg
Journal:  Vet Parasitol       Date:  2015-02-07       Impact factor: 2.738

Review 5.  Alternative Splicing in Apicomplexan Parasites.

Authors:  Lee M Yeoh; V Vern Lee; Geoffrey I McFadden; Stuart A Ralph
Journal:  mBio       Date:  2019-02-19       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.